Study details
Enrolling now
A Study Evaluating Manual Lymphatic Drainage
University of Florida
NCT IDNCT06327490ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
30
Study length
about 3.7 years
Ages
18–99
Locations
1 site in FL
About this study
This trial is testing a new way to do manual lymphatic drainage (MLD) for breast cancer patients. It compares using Indocyanine Green (ICG) to guide the MLD with traditional methods, aiming to see if it's feasible and easy for people to follow.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Indocyanine green
- 2.Undergo ICG-guided manual lymphatic drainage
- 3.Undergo Traditional manual lymphatic drainage
PhasePhase 2
DrugIndocyanine green
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
indocyanine green
Endpoints
Secondary: Breast cancer related lymphedema symptoms, Health-related quality of life
Body systems
Oncology